Related Topic: Radioisotopes

Bruce output hits new peak

Bruce output hits new peak

Bruce Power yesterday announced the achievement of a new site generation peak and set a goal of achieving a site peak of 7000 MW by 2030 as it implements its Made in Ontario post-pandemic economic recovery plan. Production of medical isotopes is also part of the plan, and the company said it plans to carry out a harvest of the medical isotope cobalt-60 before the end of the year.

Corporate 15 October 2021


Orano completes new stable isotopes laboratory

Orano completes new stable isotopes laboratory

Orano has completed construction of a new laboratory for the production of stable isotopes at its Tricastin site. The French nuclear fuel cycle company said the laboratory - the first one of its kind in France - will begin operations in the second half of 2023.

Corporate 12 October 2021


Urenco launches new radioisotope cascade

Urenco launches new radioisotope cascade

Urenco Stable Isotopes has expanded its stable and medical isotopes facility in Almelo, the Netherlands, officially opening its new Leonardo da Vinci cascade yesterday. The company - a subsidiary of uranium enrichment company Urenco Nederland BV - said the move was in response to growing demand for medical isotopes.

Corporate 06 October 2021


Cabinet approval for new South African research reactor

Cabinet approval for new South African research reactor

The South African cabinet has approved the construction of the Multipurpose Reactor to succeed the Safari-1 research reactor which is located at Pelindaba. Safari-1's operator, Necsa, said the cabinet approval allows the lead-time needed to ensure radioisotope production is not interrupted. The company has also expressed its support for the recent approval by the country's energy regulator of a ministerial determination to procure new nuclear generation capacity.

New Nuclear 30 September 2021


New nuclear medicine facilities announced for Australia

New nuclear medicine facilities announced for Australia

A new nuclear medicine manufacturing facility will be built in Australia at Lucas Heights, the home of the Australian Nuclear Science and Technology Organisation. A ministerial announcement today launched the project, saying AUD30 million (USD12.8 million) would be spent on the facility's design.

New Nuclear 30 September 2021


European medical isotope network launched

European medical isotope network launched

The PRISMAP network was recently launched which will see more than 20 European academic institutions and research centres pooling their knowledge, expertise and infrastructure to speed up the introduction of new medical radioisotopes. The network aims to provide a sustainable source of high-purity grade novel radionuclides for medical research.

Regulation & Safety 29 September 2021


Regulatory approval for new isotope production at Bruce

Regulatory approval for new isotope production at Bruce

Canada's Bruce Power has received approval from the Canadian Nuclear Safety Commission for the commercial production of the medical radioisotope lutetium-177 in its nuclear power plants. The project to produce the innovative therapeutic isotope, which is used in the treatment of prostate cancer and neuroendocrine tumours, is a partnership between Bruce Power, IsoGen, Saugeen Ojibway Nation and ITM.

Regulation & Safety 28 September 2021


Nuclear science points the way in rhino conservation

Nuclear science points the way in rhino conservation

"There is an old phrase, 'No buying; no dying", Professor James Larkin of the University of Witwatersrand told the World Nuclear Association Annual Symposium in a presentation today. "We are aiming to use nuclear science techniques to devalue rhino horn and bring an end to poaching," he said, explaining the conservation goals of the Rhisotope Project.

Regulation & Safety 10 September 2021


Viewpoint: Nuclear medicine is crucial for fighting cancer 

Viewpoint: Nuclear medicine is crucial for fighting cancer 

The nuclear medicine sector is a small part of the wider nuclear industry, but it provides some of the most pioneering technologies in healthcare - and is close to making personalised medicine a reality. Antonis Kalemis, president of Nuclear Medicine Europe and business manager for molecular imaging at Siemens Healthineers, describes how nuclear medicine also tackles the most trenchant condition in modern healthcare: cancer.

Perspectives 28 July 2021


Electrochemical Plant's revenue from stable isotopes rises by 14%

Electrochemical Plant's revenue from stable isotopes rises by 14%

Electrochemical Plant, a subsidiary of Rosatom's nuclear fuel manufacturer TVEL, recorded a 14% increase in revenue from the sale of stable isotopes in 2020, exceeding RUB1.5 billion (USD20.1 million) for the first time. The Zelenogorsk, Krasnoyarsk-based company's global market share of the stable isotope market remains over 40%, TVEL said.

Corporate 26 February 2021